These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 23600948)
1. Transcriptional network of androgen receptor in prostate cancer progression. Takayama K; Inoue S Int J Urol; 2013 Aug; 20(8):756-68. PubMed ID: 23600948 [TBL] [Abstract][Full Text] [Related]
2. FOXP1 is an androgen-responsive transcription factor that negatively regulates androgen receptor signaling in prostate cancer cells. Takayama K; Horie-Inoue K; Ikeda K; Urano T; Murakami K; Hayashizaki Y; Ouchi Y; Inoue S Biochem Biophys Res Commun; 2008 Sep; 374(2):388-93. PubMed ID: 18640093 [TBL] [Abstract][Full Text] [Related]
3. Sequencing the transcriptional network of androgen receptor in prostate cancer. Chng KR; Cheung E Cancer Lett; 2013 Nov; 340(2):254-60. PubMed ID: 23196061 [TBL] [Abstract][Full Text] [Related]
4. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1. Zaia A; Fraizer GC; Piantanelli L; Saunders GF Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720 [TBL] [Abstract][Full Text] [Related]
5. Elevated E2F1 inhibits transcription of the androgen receptor in metastatic hormone-resistant prostate cancer. Davis JN; Wojno KJ; Daignault S; Hofer MD; Kuefer R; Rubin MA; Day ML Cancer Res; 2006 Dec; 66(24):11897-906. PubMed ID: 17178887 [TBL] [Abstract][Full Text] [Related]
6. Increased androgen receptor transcription: a cause of castration-resistant prostate cancer and a possible therapeutic target. Shiota M; Yokomizo A; Naito S J Mol Endocrinol; 2011 Aug; 47(1):R25-41. PubMed ID: 21504942 [TBL] [Abstract][Full Text] [Related]
7. Integration of cap analysis of gene expression and chromatin immunoprecipitation analysis on array reveals genome-wide androgen receptor signaling in prostate cancer cells. Takayama K; Tsutsumi S; Katayama S; Okayama T; Horie-Inoue K; Ikeda K; Urano T; Kawazu C; Hasegawa A; Ikeo K; Gojyobori T; Ouchi Y; Hayashizaki Y; Aburatani H; Inoue S Oncogene; 2011 Feb; 30(5):619-30. PubMed ID: 20890304 [TBL] [Abstract][Full Text] [Related]
8. 14-3-3ζ, a novel androgen-responsive gene, is upregulated in prostate cancer and promotes prostate cancer cell proliferation and survival. Murata T; Takayama K; Urano T; Fujimura T; Ashikari D; Obinata D; Horie-Inoue K; Takahashi S; Ouchi Y; Homma Y; Inoue S Clin Cancer Res; 2012 Oct; 18(20):5617-27. PubMed ID: 22904106 [TBL] [Abstract][Full Text] [Related]
9. Methyltransferase inhibitor adenosine dialdehyde suppresses androgen receptor expression and prostate cancer growth. Shiota M; Takeuchi A; Yokomizo A; Kashiwagi E; Tatsugami K; Naito S J Urol; 2012 Jul; 188(1):300-6. PubMed ID: 22608750 [TBL] [Abstract][Full Text] [Related]
11. HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes. Axlund SD; Lambert JR; Nordeen SK Mol Cancer Res; 2010 Dec; 8(12):1643-55. PubMed ID: 21047772 [TBL] [Abstract][Full Text] [Related]
12. Evolution of the androgen receptor pathway during progression of prostate cancer. Hendriksen PJ; Dits NF; Kokame K; Veldhoven A; van Weerden WM; Bangma CH; Trapman J; Jenster G Cancer Res; 2006 May; 66(10):5012-20. PubMed ID: 16707422 [TBL] [Abstract][Full Text] [Related]
13. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression. Sun A; Tang J; Hong Y; Song J; Terranova PF; Thrasher JB; Svojanovsky S; Wang HG; Li B Prostate; 2008 Mar; 68(4):453-61. PubMed ID: 18196538 [TBL] [Abstract][Full Text] [Related]
14. Histone H2A.Z prepares the prostate specific antigen (PSA) gene for androgen receptor-mediated transcription and is upregulated in a model of prostate cancer progression. Dryhurst D; McMullen B; Fazli L; Rennie PS; Ausió J Cancer Lett; 2012 Feb; 315(1):38-47. PubMed ID: 22055461 [TBL] [Abstract][Full Text] [Related]
15. Amyloid precursor protein is a primary androgen target gene that promotes prostate cancer growth. Takayama K; Tsutsumi S; Suzuki T; Horie-Inoue K; Ikeda K; Kaneshiro K; Fujimura T; Kumagai J; Urano T; Sakaki Y; Shirahige K; Sasano H; Takahashi S; Kitamura T; Ouchi Y; Aburatani H; Inoue S Cancer Res; 2009 Jan; 69(1):137-42. PubMed ID: 19117996 [TBL] [Abstract][Full Text] [Related]
16. Beta-2-microglobulin expression correlates with high-grade prostate cancer and specific defects in androgen signaling. Mink SR; Hodge A; Agus DB; Jain A; Gross ME Prostate; 2010 Aug; 70(11):1201-10. PubMed ID: 20564426 [TBL] [Abstract][Full Text] [Related]
17. Identification of EP4 as a potential target for the treatment of castration-resistant prostate cancer using a novel xenograft model. Terada N; Shimizu Y; Kamba T; Inoue T; Maeno A; Kobayashi T; Nakamura E; Kamoto T; Kanaji T; Maruyama T; Mikami Y; Toda Y; Matsuoka T; Okuno Y; Tsujimoto G; Narumiya S; Ogawa O Cancer Res; 2010 Feb; 70(4):1606-15. PubMed ID: 20145136 [TBL] [Abstract][Full Text] [Related]
18. Regulation of FGF8 expression by the androgen receptor in human prostate cancer. Gnanapragasam VJ; Robson CN; Neal DE; Leung HY Oncogene; 2002 Aug; 21(33):5069-80. PubMed ID: 12140757 [TBL] [Abstract][Full Text] [Related]
19. Wild-type but not mutant androgen receptor inhibits expression of the hTERT telomerase subunit: a novel role of AR mutation for prostate cancer development. Moehren U; Papaioannou M; Reeb CA; Grasselli A; Nanni S; Asim M; Roell D; Prade I; Farsetti A; Baniahmad A FASEB J; 2008 Apr; 22(4):1258-67. PubMed ID: 17991730 [TBL] [Abstract][Full Text] [Related]
20. Regulation of androgen receptor levels: implications for prostate cancer progression and therapy. Burnstein KL J Cell Biochem; 2005 Jul; 95(4):657-69. PubMed ID: 15861399 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]